Aysooda Hosseinzadeh

Citace

	Všechny	Od 2020
Citace	1203	1167
h-index	9	9
i10-index	9	8

420

210

105

315

2017201820192020202120222023202420255 11 12 41 105 222 310 410 73

Spoluautoři

Khadijeh (Kimia) BarzamanIran University Of Medical ScienceE-mailová adresa ověřena na: iums.ac.ir
Mohammad Hossein KazemiPhD in Medical Immunology, Postdoctoral Researcher at University of Southern California, Los AngelesE-mailová adresa ověřena na: usc.edu
Elahe SafariDepartment of Immunology, School of Medicine & Immunology Research Center, Institute of ImmunologyE-mailová adresa ověřena na: iums.ac.ir
Sepideh SoukhtehzariFaculty of Pharmaceutical Sciences, University of British ColumbiaE-mailová adresa ověřena na: alumni.ubc.ca
Parnaz MerikhianUniversity of Texas HealthE-mailová adresa ověřena na: uth.tmc.edu
Gabriel S. BrandtAssociate Professor, Franklin & Marshall CollegeE-mailová adresa ověřena na: fandm.edu
Ahmad EsmaillzadehProfessor of Nutrition, Tehran University of Medical SciencesE-mailová adresa ověřena na: tums.ac.ir
Omid SadeghiPhD of Nutrition Sciences, Isfahan University of Medical SciencesE-mailová adresa ověřena na: nutr.mui.ac.ir
mohammad Reza eisavandE-mailová adresa ověřena na: ut.ac.ir
Sepideh MansouriTehran university of medical sciencesE-mailová adresa ověřena na: ibcrc.ir
Keivan Majidzadeh-A,Professor of Cancer Genetics, Breast Cancer Research Center, Motamed Cancer InstituteE-mailová adresa ověřena na: acecr.ac.ir
Hossein KhorramdelazadRafsanjan University of Medical Sciences, Rafsanjan, IranE-mailová adresa ověřena na: rums.ac.ir
Zahra Eslami-SLaboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, FranceE-mailová adresa ověřena na: chu-montpellier.fr
Azin TeymourzadehDepartment of Cardiovascular diseases, Mayo ClinicE-mailová adresa ověřena na: mayo.edu
leila farahmandRecombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR
Shima Moradi-kalbolandiRecombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR

Sledovat

Aysooda Hosseinzadeh

M.Sc. in Medical Immunology, Department of Immunology Faculty of Medicine Shahid Sadoughi University

E-mailová adresa ověřena na: ssu.ac.ir

Immunology & Oncology


Název Seřadit podle citací Seřadit podle roku Seřadit podle názvu	Citace Citace	Rok
Breast cancer: Biology, biomarkers, and treatments K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ... International immunopharmacology 84, 106535, 2020	742	2020
Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity A Hosseinzade, O Sadeghi, A Naghdipour Biregani, S Soukhtehzari, ... Frontiers in immunology 10, 51, 2019	199	2019
Breast cancer immunotherapy: Current and novel approaches K Barzaman, S Moradi-Kalbolandi, A Hosseinzadeh, MH Kazemi, ... International immunopharmacology 98, 107886, 2021	89	2021
Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER S Moradi-Kalbolandi, A Hosseinzade, M Salehi, P Merikhian, ... Journal of Pharmacy and Pharmacology 70 (7), 841-854, 2018	44	2018
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy A Hosseinzadeh, P Merikhian, N Naseri, MR Eisavand, L Farahmand Cancer Cell International 22 (1), 110, 2022	27	2022
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk K Barzaman, R Vafaei, M Samadi, MH Kazemi, A Hosseinzadeh, ... Cancer Cell International 22 (1), 259, 2022	24	2022
Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance S Mansouri, L Farahmand, A Hosseinzade, Z Eslami-S, K Majidzadeh-A Biomedicine & Pharmacotherapy 93, 1320-1325, 2017	23	2017
ER-α36 interactions with cytosolic molecular network in acquired tamoxifen resistance A Teymourzadeh, S Mansouri, L Farahmand, A Hosseinzade, ... Clinical breast cancer 17 (6), 403-407, 2017	18	2017
Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells A Hosseinzadeh, F Poursoleiman, AN Biregani, A Esmailzadeh Cancer Cell International 23 (1), 114, 2023	13	2023
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study R Vafaei, M Samadi, A Hosseinzadeh, K Barzaman, MR Esmailinejad, ... Cancer Cell International 22, 1-9, 2022	9	2022
& Farahmand, L.(2020) K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ... Breast cancer: Biology, biomarkers, and treatments. International …, 0	6
Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity, Front. Immunol. 10 (2019) 51 A Hosseinzade, O Sadeghi, AN Biregani, S Soukhtehzari, GS Brandt, ...	5	2019
Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression MS Barough, N Jalili, S Shafiee, M Salehi, N Naseri, MA Javidi, ... International Immunopharmacology 124, 110792, 2023	3	2023
Metabolism plays the key roles in Th cells differentiation A Hosseinzadeh, S Soukhtehzari, M Ghaedi, R Mansouri Reumatismo 68 (4), 176-182, 2016	1	2016

Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.

Články 1–14

Citace za rok

Duplicitní citace

Sloučené citace

Přidat spoluautorySpoluautoři

Sledovat

Citace

Spoluautoři